Patents/Assignees

Purinomia Biotech, Inc.

1 patent in portfolio

US12098212utility2024
Methods and Compositions for Promoting and Potentiating T-cell Mediated Immune Responses Through ADCC Targeting of CD39 Expressing Cells
0 cites